City State Bank’s Moderna MRNA Stock Holding History

City State Bank’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.5K	Hold	50	–	–	﹤0.01%	682
2026 Q1	$2.54K	Hold	50	–	–	﹤0.01%	670
2025 Q4	$1.48K	Hold	50	–	–	﹤0.01%	695
2025 Q3	$1.29K	Sell	50 -100	-67%	-$2.79K	﹤0.01%	683
2025 Q2	$4.14K	Hold	150	–	–	﹤0.01%	611
2025 Q1	$4.25K	Buy	150 +50	+50%	+$1.77K	﹤0.01%	609
2024 Q4	$4.16K	Buy	100 +50	+100%	+$2.39K	﹤0.01%	599
2024 Q3	$3.34K	Hold	50	–	–	﹤0.01%	619
2024 Q2	$5.94K	Hold	50	–	–	﹤0.01%	538
2024 Q1	$5K	Sell	50 -75	-60%	-$7.56K	﹤0.01%	579
2023 Q4	$12K	Hold	125	–	–	0.01%	451
2023 Q3	$13K	Buy	125 +50	+67%	+$5.58K	0.01%	432
2023 Q2	$9K	Hold	75	–	–	﹤0.01%	486
2023 Q1	$12K	Sell	75 -75	-50%	-$12.4K	0.01%	442
2022 Q4	$27K	Hold	150	–	–	0.02%	337
2022 Q3	$18K	Hold	150	–	–	0.01%	359
2022 Q2	$21K	Hold	150	–	–	0.01%	344
2022 Q1	$26K	Hold	150	–	–	0.02%	350
2021 Q4	$38K	Buy	+150	New	+$43.9K	0.02%	318

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

City State Bank's MRNA Position: Q2 2026 in Review

City State Bank held its Moderna (MRNA) position steady in Q2 2026 at 50 shares worth $3.5K. The position accounts for ﹤0.01% of the portfolio, ranked #682.

City State Bank first reported a position in MRNA in Q4 2021 and has held it in 19 quarters since. The position peaked at $38K in Q4 2021. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

City State Bank held 50 shares of Moderna worth $3.5K as of Q2 2026.
City State Bank left its Moderna share count unchanged in Q2 2026.
Moderna made up ﹤0.01% of City State Bank's portfolio in Q2 2026, its #682 holding.
City State Bank first reported a position in Moderna in Q4 2021 and has held it in 19 quarters since.
City State Bank's Moderna position peaked at $38K in Q4 2021.
784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on City State Bank's 13F filing for Q2 2026, filed 14 Jul 2026.